GSK3B and osteoporosis: Our previous study showed that the dihydrochalcone phlorizin stimulated osteoblastogenic bone formation through enhancing β-catenin activity via glycogen synthase kinase-3β (GSK-3β) inhibition in a model of senile osteoporosis [23].